Wells Fargo Maintains Equal-Weight on Conmed, Raises Price Target to $49
Benzinga Newsdesk 3 days ago
Analyst RatingsNewsPrice Target
Wells Fargo analyst Larry Biegelsen maintains Conmed (NYSE:CNMD) with a Equal-Weight and raises the price target from $46 to $49.
Wells Fargo analyst Larry Biegelsen maintains Conmed (NYSE:CNMD) with a Equal-Weight and raises the price target from $46 to $49.